Carotid endarterectomy

Series
Peripheral vascular
Status
Ongoing
Date
Number of report
067

Ask the expert

(we accept only company emails)

The report presents a summary of the reimbursement situation for carotid endarterectomy in Europe.

The following procedures will be considered in the report:

  • surgical carotid endarterectomy;
  • percutaneous transluminal carotid artery angioplasty and stenting.

The analysis will cover reimbursement for the procedures in atherosclerotic occlusion and stenosis of carotid arteries during hospital admission.

The only reimbursement within public / statutory health insurance systems is considered.

The report includes essential information about reimbursement, including:

  • Brief country-specific overview of reimbursement system
  • Procedure coding for technology
  • Diagnosis coding
  • Payment mechanism for technology
  • Reimbursement tariffs for technology
  • Restrictions on indications or scenarios for the use of technology
  • Policy considerations by payers and policy-makers about technology

Reimbursement information is provided for the following geographies:

  • Austria
  • Belgium
  • Denmark
  • England (UK)
  • Finland
  • France
  • Germany
  • Italy
  • The Netherlands
  • Norway
  • Sweden
  • Switzerland

Manufacturers of devices for carotid endarterectomy include:

  • Abbott Vascular (RX Acculink, Xact, RX Accunet, Emboshield NAV6)
  • Allium Medical (Gardia)
  • Balton (Mer)
  • Boston Scientific (Wallstent)
  • Cordis (PRECISE PRO RX, AVIATOR Plus PTA, ANGIOGUARD RX)
  • Gore Medical (GORE)
  • InspireMD (CGuard)
  • Medtronic (Protégé RX, SpiderFX, Mo.Ma Ultra)
  • Optimed (Sinus-Carotid RX)
  • Silk Road Medical (ENROUTE, ENHANCE)
  • Terumo Corporation (Roadsaver)

Table of content is not available at the moment. Report is still ongoing.

There are no relevant news at the moment
(we accept only company emails)